AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
Stablecoin Development Corporation
XASE · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG001SQYBY0
1.00▼ 0.10 (-9.09%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
—
EV / Revenue
—
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
—
Net Income (TTM)
EBITDA
—
Diluted EPS (TTM)
EBITDA Margin
—
Net Debt
Trading Information
Previous Close
1.10
Day's Range
1.00 – 1.15
52-Week Range
0.78 – 9.82
Volume
6.7M
Avg Volume
30.9M
Share Statistics
Shares Outstanding
Employees
4
Exchange
XASE
Listed
2000-04-26
Share count as of July 27, 2026

Stablecoin Development Corporation (SDEV) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Stablecoin Development Corporation (SDEV)
What is Stablecoin Development Corporation's Market Cap?
Stablecoin Development Corporation's Market Cap is $50.6M, based on as-reported figures from SEC (XBRL) filings.
What is Stablecoin Development Corporation's Enterprise Value?
Stablecoin Development Corporation's Enterprise Value is $43.6M, based on as-reported figures from SEC (XBRL) filings.
What is Stablecoin Development Corporation's Net Income (TTM)?
Stablecoin Development Corporation's Net Income (TTM) is -$125.2M, based on as-reported figures from SEC (XBRL) filings.
What is Stablecoin Development Corporation's Diluted EPS (TTM)?
Stablecoin Development Corporation's Diluted EPS (TTM) is -2.47, based on as-reported figures from SEC (XBRL) filings.
What is Stablecoin Development Corporation's Net Debt?
Stablecoin Development Corporation's Net Debt is -$7.0M, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · SDEVAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Staking revenue—
YoY growth———
Unrealized gain on digital assets——
Operating expenses:
General and administrative
Impairment of long-lived assets
Total operating expenses
% of revenue245.6%—249.1%
Operating loss
% of revenue-2440.8%—-241.1%
Non-cash loss on fair value of warrant liabilities in excess of proceeds at issuance——
Non-cash gain on changes in fair value of warrant liabilities
Other expense, net
Total non-operating income (expense), net——
Net (loss) income from continuing operations, before taxes——
Income tax (benefit)——
Net (loss) income from continuing operations
Net income from discontinued operations, net of taxes (Note 13)
Net (loss) income attributable to common stockholders
% of revenue-1861.7%—-248.2%
Basic and diluted net (loss) income per share attributable to common stockholders:
Basic (loss) earnings per share attributable to common stockholders (in dollars per share)—
Diluted (loss) earnings per share attributable to common stockholders (in dollars per share)—